Downloading the app
You can download the app from the and stores.
RPharmS-iRx is designed to work on iPhone 4+ and iPad 2+ (including iPad
Mini) on iOS7 and above, or Android devices running 4.0 (Ice Cream
Sandwich) and above.
Opening the app for the first time
Once you have downloaded the app on your mobile device and open it
for the first time you will be prompted to ensure you have a back-up
facility activated on your phone, such as iCloud, or that you are
manually backing-up your smartphone/tablet regularly. This is to ensure
that your data is not lost accidentally, should you lose or reset your
You will then be prompted to login in using your Royal Pharmaceutical
Membership number and surname. When entering your surname, please make
sure to type it correctly as this field is case-sensitive e.g. 'Jones'
rather than 'jones'.
If you experience issues logging in, please log in to the londep.info website first and verify your details in My Profile.
You can sign out of the app later by going to the 'Settings' screen.
The RPharmS-iRx app contains a formulary of editable drug templates. The list has been populated with the 200 most commonly prescribed and specialist medicines across primary and secondary care. You can view an alphabetical list of these medicines from the 'Drugs' screen. You can also access this list from the 'Drug category' screen.
An 'S' next to a drug name denotes a specialist medicine. You can add new drugs by clicking the + symbol on the Drugs screen.
How to populate a drug template
When you click on a drug you will see a list of editable sections,
including BRAINS&AIMS - you can add text notes, images, web links or
voice notes to each of these areas:
Mechanism of action,
pharmacodynamics, pharmacokinetics, chemistry, physicochemical
properties. Compare these parameters with other drugs within the same
Include both licensed and unlicensed indications, any local formulary considerations could be added here.
Which patients or conditions
will benefit from this drug and how much will they benefit. Include
information from key publications on how much benefit a patient is
expected to experience. Think about the level of evidence available for
this drug for a particular indication.
This section could include some risk vs benefit information.
What harm might come to your patient, their carer, or the general
- Adverse effects
Common and serious adverse effects of the drug. For each reaction
you could describe how they can be prevented or treated and whether they
are dose-dependent and how they should be reported.
Common and serious drug interactions. The interactions may be
pharmacokinetic and/or pharmacodynamics, and may be beneficial or
detrimental, and antagonistic or synergistic. Describe how the
interaction should be managed or whether it should be avoided
- Necessary prophylaxis
This section should contain details about any prophylaxis
that may need to be prescribed with this drug to help prevent or reduce
the severity of adverse effects.
- Susceptible groups
This section should contain information about patient groups
or conditions that may respond differently to this drug (see cautions
and contra-indications in the BNF). Think about Age, Sex, Diseases (e.g.
renal or hepatic), Genetic, Altered physiology, Pregnancy and
This section should contain
information regarding the methods by which the drug can be administered.
Think about I-DRAFFT: ID drug, patient, Doses (starting dose, titration
regimens), Routes (when might each route be used, dose conversions
between preparations), Allergy-check, Formulation, Frequency and Timing
(pharmacokinetics, half-lives, missed doses, and overdoses). What are
the parenteral administration requirements e.g. concentration, volume,
rate and duration? Are there compatibility issues (solvent, other
drugs)? How should the drug be administered to a patient that is not
swallowing? What action should be taken if a patient misses a dose, or
takes too much?
What information should be discussed regarding this drug with the
patient, carer, relatives, nurses, pharmacists, doctors. Reflect on the
other BRAINS and AIMS.
This section should contain details about the parameters that should
be monitored in the patient to detect beneficial and adverse effects.
These may be both subjective and objective, and may be from a variety of
sources e.g. clinical, biochemical, haematological. Think about whether
this drug requires therapeutic drug monitoring (TDM: PK/PD, timing,
interpretation and dose adjustment). Are there any equations that can be
used to help interpret dose and provide details of dosage adjustments?
Identify appropriate duration of treatment and reasons for stopping
(monitoring) or importance of not stopping and special precautions for
You can share your drug template via email direct from the app, simply click the Share button in the top right hand corner.